Global Point of Care Hematology Diagnostics Market Size To Exceed USD 4.6 Billion By 2035 | CAGR of 5.70%
Category: HealthcareGlobal Point of Care Hematology Diagnostics Market Size To Exceed USD 4.6 Billion By 2035
According to a research report published by Spherical Insights & Consulting, the Global Point of Care Hematology Diagnostics Market Size is Expected to Grow from USD 2.5 Billion in 2024 to USD 4.6 Billion by 2035, at a CAGR of 5.70% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 240 pages with 130 Market data tables and figures & charts from the report on the "Global Point of Care Hematology Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Type (Completed Blood Count (CBC), Coagulation Testing, Hemoglobin Testing and Anemia Diagnosis, and Others), By Mode of Prescription (Prescription based product and OTC based product), By End User (Diagnostic Centers, Hospitals, Blood Banks & Transfusion Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/point-of-care-hematology-diagnostics-market
The point of care hematology diagnostics market is the industry for hematological tests that analyze blood components at or near the patient’s location, rather than in a central laboratory. Point of care hematology diagnostics is a clinical laboratory test conducted close to the site of patient care where treatment is provided. Integration of digital technologies, including AI and cloud-based data management, in the diagnostics landscape for improving the accuracy and speed of hematological testing and enabling better data tracking & remote monitoring is escalating market growth opportunities. An increasing demand for immediate clinical decisions, along with an upsurging demand for rapid and accurate blood testing at the patient’s bedside, is contributing to driving the market demand. Further, an increasing prevalence of blood-related disorders, including anemia, leukemia, and haemophilia, is anticipated to propel the market. On the contrary, an increased cost of devices, concerns associated with the accuracy & reliability of PoC testing, and a shortage of skilled workforce are challenging the market growth.
The completed blood count (CBC) segment dominated the market with the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the type, the point of care hematology diagnostics market is divided into completed blood count (CBC), coagulation testing, hemoglobin testing and anemia diagnosis, and others. Among these, the completed blood count (CBC) segment dominated the market with the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period. The widespread application of completed blood count for the detection of disorders, including anemia, infection and leukemia, autoimmune disorders, bone marrow disorders, and lymphoma, is driving the market growth.
The prescription based product segment accounted for the dominant market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the mode of prescription, the point of care hematology diagnostics market is divided into prescription based product and OTC based product. Among these, the prescription based product segment accounted for the dominant market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. An increasing prioritization towards prescription-based point of care hematology devices, owing to their reliability, regulatory approval, and established treatment protocols, is driving the market.
The hospitals segment accounted for the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the end user, the point of care hematology diagnostics market is divided into diagnostic centers, hospitals, blood banks & transfusion centers, and others. Among these, the hospitals segment accounted for the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. An increasing demand for rapid diagnostics in non-traditional care settings, as well as the availability of advanced diagnostic infrastructure, are responsible for driving the market in the hospitals segment.
North America is expected to hold the majority share of the global point of care hematology diagnostics market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global point of care hematology diagnostics market during the forecast period. The presence of well-established healthcare infrastructure, with the growing focus towards early disease detection and preventive care, is driving the regional market growth for point of care hematology diagnostics. Further, demand for POC diagnostic tests, owing to their ability to deliver immediate results, aids in propelling the market demand.
Asia Pacific is anticipated to grow at the fastest pace in the global point of care hematology diagnostics market during the forecast period. An increasing awareness about the early detection, along with an upsurging need for rapid & accurate diagnostic results, aids in driving the point of care hematology diagnostics market. The increased prevalence of hematological and chronic diseases in densely populated countries, including China and India, is anticipated to drive the market demand.
Europe is anticipated to hold a significant share of the point of care hematology diagnostics market during the predicted timeframe. This is attributed to the adoption of technical advancements for enhancing the quality of point of care diagnostics and an increasing number of in-house hospital laboratories. Further, the regions’ significant presence of a well-established healthcare framework, with an increasing prevalence of blood-related disorders, is driving the market.
Major vendors in the global point of care hematology diagnostics market are Abbott, Madison Medical Diagnostics LLC, Sysmex Corporation, EKF Diagnostics, Danaher Corporation, Siemens Healthineers, PixCell Medical Technologies Ltd, F.Hoffman-La Roche Ltd, Thermo Fisher Scientific, Bio-Rad Laboratories, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In February 2024, CellaVision and Sysmex signed a strategic alliance agreement to reinforce and extend their joint leadership position within hematology and seize new opportunities for optimized diagnostics.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the point of care hematology diagnostics market based on the below-mentioned segments:
Global Point of Care Hematology Diagnostics Market, By Type
- Completed Blood Count (CBC)
- Coagulation Testing
- Hemoglobin Testing and Anemia Diagnosis
- Others
Global Point of Care Hematology Diagnostics Market, By Mode of Prescription
- Prescription based product
- OTC based product
Global Point of Care Hematology Diagnostics Market, By End User
- Diagnostic Centers
- Hospitals
- Blood Banks & Transfusion Centers
- Others
Global Point of Care Hematology Diagnostics Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?